Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2025-12-29 @ 5:58 AM
Study NCT ID:
NCT00311168
Status:
COMPLETED
Last Update Posted:
2021-08-12
First Post:
2006-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
Sponsor:
Abbott Medical Devices
Organization:
Study Overview
Official Title:
Reduce Ventricular Pacing Using Ventricular Intrinsic Preference: VIP™ Study
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: